Sharp Increase in Hospitalizations Among UK's Young People Due to E-Cigarettes

Regulations by 2FIRSTS.ai

Apr.23.2024

Sharp Increase in Hospitalizations Among UK's Young People Due to E-Cigarettes

E-cigarette-related hospitalizations in UK's under-20s surged 733% in past four years, NHS data reveals. Significant rise in children affected.

According to a report by the New York Post on April 22, the latest data from the UK's National Health Service (NHS) indicates that the number of people under the age of 20 in the UK who have been hospitalized due to e-cigarette use has increased by 733% over the past four years, starting from 2020.

According to statistical data, in 2020, out of 97 cases of hospitalized patients, 19 were children; in 2021, out of 300 hospitalized cases, 19 were children; this number further increased in 2022, with 5 out of 457 cases being children; in 2023, 50 children were hospitalized out of 365 cases, including 11 children under the age of 4.

Furthermore, the report also points out that the number of female patients hospitalized due to e-cigarette-related issues is increasing, growing by 57% compared to 2023.

References:

[1] Child vaping hospitalizations skyrocket 733% — including kids under 5

Also Read:

[1] Wales Plans to Ban Disposable E-cigarettes by 2025

[2] Alarming Increase in Hospitalizations of Children Due to E-Cigarettes

[3] Rising Trend of Smoking Among Affluent Women Under 45

[4] British Government Provides Tax-Free Tobacco to Ukrainian Soldiers Training in the UK

[5] Chill Brands CEO Suspended for Alleged Insider Trading Actions

[6] ELFBAR, LOST MARY Launch Reusable E-Cigarettes in Response to UK Disposable Ban

#Europe #Open system e-cigarettes #UK #Public opinion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

STMA to Hold Hearing on License Leasing Case in Shenzhen

The State Tobacco Monopoly Administration (STMA) announced a public hearing will be held on Nov. 11 at 9 a.m. in Bao’an District, Shenzhen, regarding Shenzhen Biaogan Zhizao Technology Co., Ltd. accused of leasing its tobacco retail license.

Oct.31 by 2FIRSTS.ai

EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia

The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.

Dec.10 by 2FIRSTS.ai

Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates

According to Gulf News, Sweden is nearing the World Health Organization’s smoke-free threshold, with daily smoking falling below 5%. Two decades of public health efforts and the growing use of lower-risk alternatives such as Snus and tobacco-free nicotine pouches have contributed to this shift, alongside declines in tobacco-related deaths and lung cancer cases.

Dec.04 by 2FIRSTS.ai

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches

CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.